Bemiparin is primarily used for the prevention and management of venous thromboembolism (VTE), which includes conditions such as deep vein thrombosis and pulmonary embolism. It belongs to the class of anticoagulant medications known as low molecular weight heparins (LMWHs).
Additionally, Bemiparin is also used for the prevention of VTE in patients undergoing general or orthopaedic surgery.
Bleeding
Bruising
Hematoma formation at the injection site
Thrombocytopenia
Allergic reactions
Bemiparin is an anticoagulant, specifically falling under the category of low molecular weight heparins.
It primarily acts by inhibiting clot formation. It enhances the activity of antithrombin III, a natural anticoagulant in the body, which in turn inhibits factor Xa and, to a lesser extent, factor IIa (thrombin). This dual action reduces the formation of fibrin clots, thereby preventing the development or expansion of thrombi (blood clots).
BDS, MDS
BMS, FMC, MD Resident
Bemiparin is available as an injectable solution to be administered directly under the skin (subcutaneous administration). This formulation ensures that the medicine is absorbed into the bloodstream efficiently.
Bemiparin is intended for use in adult patients only. It is not recommended for children due to the specific dosing and monitoring required.
Bemiparin is contraindicated in patients with active major bleeding.
It is also contraindicated in patients with a history of heparin-induced thrombocytopenia (HIT).
Bemiparin should not be used in individuals with severe uncontrolled hypertension.
Patients with known hypersensitivity to Bemiparin or any low molecular weight heparins should avoid this medication.
This medicine can interact with antiplatelet agents (such as aspirin, and clopidogrel), NSAIDs (such as ibuprofen, and naproxen), thrombolytic agents (such as alteplase, and reteplase), and other anticoagulants (like warfarin, dabigatran).
An overdose of Bemiparin may lead to excessive bleeding. If you suspect an overdose, it is important to seek immediate medical attention.
If a dose of Bemiparin is missed, it should be administered as soon as you remember. However, if it is nearly time for your next dose, skip the missed one and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
If experiencing mild bruising at the injection site, consider rotating the injection sites each time.
Staying hydrated may help alleviate mild side effects such as headaches.
Bemiparin does not usually affect your ability to drive or operate machinery. However, be mindful of any signs of dizziness or weakness which could impair your ability to perform these tasks safely.
Bemiparin should only be used during pregnancy or while breastfeeding if the potential benefits outweigh the risks. Pregnant or nursing mothers should consult their doctor before starting this medication.
Patients with renal impairment should use Bemiparin with caution due to increased risks of bleeding.
Those with liver disorders must also be cautious because liver problems can alter how this medicine is metabolized and excreted from the body.
Maintain adequate hydration to support overall blood health while on Bemiparin.
Engage in regular physical activity such as walking, which can help prevent deep vein thrombosis by promoting good circulation.
Avoid wearing tight clothing or sitting for extended periods. Regular stretching and movement can further aid circulation.
If prone to falls or injuries, take safety precautions around the home to reduce the risk of bleeding complications from bumps or falls.
Frequently asked questions
Bemiparin works by binding to and enhancing the activity of a natural anticoagulant in the body known as antithrombin III. This leads to the inactivation of two key enzymes, factor Xa and thrombin, which play a central role in the blood clotting process. By inhibiting these enzymes, Bemiparin prevents the formation of fibrin and thus, the development of blood clots.
Bemiparin is administered through subcutaneous injections, which means it is injected into the fatty layer of tissue just under the skin.
Yes, Bemiparin can cause bruising or bleeding as it inhibits blood clotting. The most common side effects of Bemiparin are related to its anticoagulant activity and include bleeding, bruising, and hematoma formation at the injection site.
Bemiparin should be used with caution in patients with renal impairment, as the risk of bleeding may be increased. It is important for such patients to have regular check-ups with their doctor.
Bemiparin works quickly to prevent blood clots, with its anticoagulant effects beginning soon after injection and lasting for about 24 hours.
Bemiparin is not known to affect fertility; however, if you have concerns, it’s important to discuss them with your doctor, especially if you’re planning to conceive.
Bemiparin can be used long term in certain cases, such as ongoing prevention of blood clots, but the duration of use should be determined by your doctor.
Company
About UsHealth ArticleHealth StoriesDiseases & Health ConditionsAll MedicinesAll BrandsNeed HelpFAQSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.7.11
Our Payment Partners